Researchers at the University of Cincinnati (UC) have identified a new genetic target for diuretic therapy in patients with fluid overload - like those with congestive heart failure, liver cirrhosis or kidney failure. These results, presented in the July 30 advance online edition of the journal Proceedings of the National Academy of Sciences (PNAS), may lead to the first new diuretic therapy in 25 years and could help patients who experience diuretic resistance...
More...
More...